Evidence map›Paper›PMID 37967996›Full record

ArticleBMJ open2023

Health-related quality of life and associated factors among patients with schizophrenia at comprehensive specialised hospitals in the Northwest Ethiopia: a multicentre cross-sectional study.

Fasil Bayafers Tamene, Feser Dula Sema, Endalamaw Aschale Mihiretie, Tewodros Solomon Siyum, Ashenafi Kibret Sendekie

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fasil Bayafers TameneDepartment of Pharmacy, Debre Markos University College of Health Science, Debre Markos, Ethiopia fasil.baya@gmail.com.ORCID 0009-0005-3026-6584
Feser Dula SemaDepartment of Clinical Pharmacy, University of Gondar, Gondar, Ethiopia.
Endalamaw Aschale MihiretieDepartment of Pharmacy, Bahir Dar University College of Medical and Health Sciences, Bahir Dar, Ethiopia.
Tewodros Solomon SiyumDepartment of Pharmacy, Wollo University, Dessie, Ethiopia.
Ashenafi Kibret SendekieDepartment of Clinical Pharmacy, University of Gondar, Gondar, Ethiopia.ORCID 0000-0001-5982-853X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to assess the health-related quality of life (HRQoL) and associated factors among patients with schizophrenia at comprehensive specialised hospitals in Northwest Ethiopia. DESIGN AND

settingA cross-sectional study was conducted among 422 patients with schizophrenia who were followed at comprehensive specialised hospitals in Northwest Ethiopia from 1 June to 30 August 2022.

participantsAll adult patients with schizophrenia who had regular follow-up in the outpatient departments of the selected hospitals were study participants.

main outcome measuresThe main outcome of this study was HRQoL which was measured using the WHO Quality of Life Scale-Bref Version. Data entry and analysis were done using Epi-data version 4.6.1 and SPSS version 24, respectively. Linear regression was used to assess the association between quality of life and independent variables. Variables with a p value <0.05 at a 95% CI were considered statistically significant.

resultsThe mean score of the overall Quality of Life Scale-Brief Version was 22.42±3.60. No formal education (ß=-1.53; 95% CI: -2.80 to -0.27), duration of treatment (ß = -3.08; 95% CI: -4.71 to -1.45), comorbidity (ß=-1.14; 95% CI: -1.99 to -0.29), substance use (ß=-0.89; 95% CI: -1.56 to -0.23), extrapyramidal side effects (ß=-2.02; 95% CI: -2.90 to -1.14), non-adherence (ß=-0.83; 95% CI: -1.44 to -0.23), and antipsychotic polypharmacy (ß=-1.77; CI: -2.57 to -0.96) were negatively associated with quality of life. CONCLUSION AND RECOMMENDATION: In this study, the social domain was recorded as having the lowest mean score, which may indicate that patients with schizophrenia could need better psychosocial support. Patients with a longer duration of treatment, who had comorbid illnesses, were substance users, developed EPS, were non-adherent to medications and were on antipsychotic polypharmacy, needs critical follow-up to improve HRQoL.

Indexed as

Antipsychotic AgentsSchizophreniaAdultCross-Sectional StudiesEthiopiaHospitalsHumansQuality of LifeAntipsychotic Agentsadult psychiatryobservational studyquality of lifeschizophrenia & psychotic disorderssubstance misuse

Identifiers

PMID37967996
PMCPMC10660835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.